Cellusion participated in “BIO Asia-Taiwan 2024” and CFO Takuya Kaneko made a pitch at the Investment Summit

BIO Asia-Taiwan 2024, jointly organized by the Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO), was held at the Nangang Exhibition Center in Taipei, Taiwan from July 24, 2024.

The conference showcases the latest information on the biotech industry in the fields of therapeutic, diagnostic, medical equipment, and service sectors, and brings together biotech leaders and investors from around the world. This year’s conference theme was “Global View, Asian Touch,” and included internationally renowned speakers, company presentations from Asia and around the world, BIO One-on-One Partnering™ meetings, a full program of focus symposia and workshops, and an international exhibition.

On July 25, an Investment Summit was held to present to investors, and our CFO Takuya Kaneko took the stage. Among the many Taiwanese biotech companies in attendance, he explained Cellusion’s vision for the regenerative medicine business. Many opinions were exchanged after his speech.

EVP & COO Joji Hayashida also visited Taipei to discuss future business opportunities with local companies and accelerators.
Through this visit, we were able to gain a renewed sense of the market and business development possibilities, and it was a valuable opportunity to further grow our business.